Merethoxylline Procaine

CHEMBL1200443 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
764.2 g/mol
LogP
Phase
4

A combination form of merethoxylline, sharing the same therapeutic uses.

Molecular Weight

764.2000 g/mol

TPSA

151.00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

SMILES

CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.COCCOC(CNC(=O)C1=CC=CC=C1OCC(=O)O)C[Hg+].[OH-]

InChI

InChI=1S/C15H20NO6.C13H20N2O2.Hg.H2O/c1-11(21-8-7-20-2)9-16-15(19)12-5-3-4-6-13(12)22-10-14(17)18;1-3-15(4-2)9-10-17-13(16)11-5-7-12(14)8-6-11;;/h3-6,11H,1,7-10H2,2H3,(H,16,19)(H,17,18);5-8H,3-4,9-10,14H2,1-2H3;;1H2/q;;+1;/p-1

Molecular Formula

C28H41HgN3O9

HBD / HBA

4 / 11

Rotatable Bonds

18

Heavy Atoms

41

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

A combination form of merethoxylline, sharing the same therapeutic uses.

Yes, Merethoxylline Procaine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200443. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 72710718. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.